Publiziert in: Marktpuls, Unternehmen
Frei

Invitation to the Conference Call - Medacta 2022 Annual Results Montag, 13. März 2023 - 07:01

eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzUxMiJ9.eyJpc3MiOiJmaWxlX3N0b3JhZ2UiLCJpYXQiOjE1NjgwMjI5MDYsInRva2VuX3V1aWQiOiI3YjBjMTZiNS0zMjI2LTQ3MjYtYTUzMS0yYTQ2Mjg3YjE5OTAifQ._gMqbfmjmphB6paw2UAnOQVMphuAlajhoXwl3dw9waMRKIurLjbN8ST2sDf3uCx6RQcVPAMgcthmhPOobYU4lQ

Medacta Group SA: 2022 Annual Results

Dear Madam or Sir,
 
You are cordially invited to attend our conference call concerning the 2022 Annual Results of Medacta Group SA.
 
Francesco Siccardi (CEO) and Corrado Farsetta (CFO) will present the results followed by a question and answer session. The call will be held in English. Registration is not necessary.
 

Date

March 17, 2023

Time

3.00 pm (CET)

Dial-in numbers

CH: +41 225954727

DE: +49 6917415713

UK: +44 1212818003

US: +1 7187058794

IT:   +39 0236213011

 

The press release of the 2022 Annual Results as well as a corresponding presentation will be available on our company’s website https://www.medacta.com/EN/financial-reports as of 7.00 am CET on the reporting day.

To follow the presentation, please use the below webcast link (no audio signal):  

https://event.choruscall.com/mediaframe/webcast.html?webcastid=MwA1Q1ok

We look forward to welcoming you at our conference call.

Best regards

Medacta Group SA
Giorgio Botta, Head of Investor Relations 
Phone: +41 91 696 14 95
investor.relations@medacta.ch

 
About Medacta
Medacta is an international company specializing in the design, production, and distribution of innovative orthopaedic products, as well as in the development of accompanying surgical techniques. Established in 1999 in Switzerland, Medacta is active in joint replacement, spine surgery, and sports medicine. Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Medacta's innovation, forged by close collaboration with surgeon leaders globally, began with minimally invasive surgical techniques and has evolved into personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 40 countries.